Visionix and Revenio Combine Forces—Creating a Leading Turnkey Solutions Provider in the Global Eye Care Market

Dear Customers and Followers,

I am very pleased to share exciting and important news with you. On April 13th, 2026, iCare’s parent company Revenio Group Corporation and the French company LT International SAS, the parent company of Visionix International group (“Visionix”), signed an agreement under which Revenio will acquire the entire share capital of Visionix.

While the legal structure is an acquisition, the strategic intent is to bring together two highly complementary businesses, enabling accelerated growth and value creation with greater scale and synergies. The combination will be managed as a partnership of strengths, along with leadership, capabilities, and know-how from both companies helping shape the next chapter of the combined group.

Together, we are creating a leading turnkey solutions provider in the global eye care market. With very limited product overlap and a strong complementary commercial presence, the transaction creates the foundation for a broader and more integrated eye care offering.

In an increasingly evolving market, this is a mutually strengthening arrangement and a highly complementary fit, with no significant overlap between the businesses. Together with Revenio, this step significantly strengthens our position in the global eye care market. We will create a seamlessly connected eye care offering, expanding our capabilities across diagnostics, imaging, and other optical solutions. For our customers, this means access to a broader, more integrated set of eye care solutions from a stronger partner.

The stock exchange release can be found on Revenio’s website: www.reveniogroup.fi/en/releases

Why we are joining forces

By joining forces with Revenio, we combine highly complementary technologies, expertise and global reach. Together, we will create a more connected offering in eye care, expanding our capabilities across diagnostics, imaging, and other optical solutions. This step enables us to respond even better to the needs of modern practices and the changing dynamics of the global eye care market.

What will this mean to you

Our ambition is clear: to make working with us simpler, more seamless and more valuable for you.

Together with Revenio we will offer:

• A broad and integrated product and solution offering across diagnostics, imaging,and other optical solutions
• Combined software, telehealth, AI and data capabilities, supporting the shift toward more connected, efficient, and service-oriented models of eye care
• Solutions designed to support specific clinical and operational workflows
• Strong long-term support from a partner committed to advancing eye care with you

What will happen next

Our priority remains clear: to maintain and develop our collaboration with you. For the time being, the transaction will not impact existing business and your points of contact will remain the same.

Both organizations share a strong commitment to innovation, quality, and customer success. Together, we are entering a new phase of growth with the scale, expertise, and capabilities to provide even greater support to our customers.

We look forward to continuing our collaboration with you.

Marc Abitbol, PhD

CEO, Visionix